search
view_module view_stream
Novel compounds for treatment of neurodegenerative disease and chronic pain
Technology No. 20160321
Novel compounds for treatment of neurodegenerative disease and chronic pain
Find out more
First-generation degraders for class I bromodomain-containing proteins
Technology No. 2022-132
First-generation degraders for class I bromodomain-containing proteins
Find out more
NOD-2-active carboxamide compounds as vaccine adjuvants
Technology No. 2019-001
NOD-2-active carboxamide compounds as vaccine adjuvants
Find out more
Lentivirus for keratinocyte immortalization and immortalized keratinocyte cell lines
Technology No. 2020-286
Lentivirus for keratinocyte immortalization and immortalized keratinocyte cell lines
Find out more
High-throughput screening assay for sickle cell disease drug discovery
Technology No. 2019-329
High-throughput screening assay for sickle cell disease drug discovery
Find out more
Mouse-derived FSHD muscle cell lines
Technology No. 2019-199
Mouse-derived FSHD muscle cell lines
Find out more
Generating teratoma-derived skeletal muscle stem cells
Technology No. 20160361
Generating teratoma-derived skeletal muscle stem cells
Find out more
Small molecules with antiproliferative activity against pancreatic cancer cells
Technology No. 20160388
Small molecules with antiproliferative activity against pancreatic cancer cells
Find out more
Steerable magneto-photonic particles for targeted delivery and collection of light
Technology No. 2023-107
Steerable magneto-photonic particles for targeted delivery and collection of light
Find out more
AgRP-Derived melanocortin-5 receptor peptide antagonists
Technology No. 2020-161
AgRP-Derived melanocortin-5 receptor peptide antagonists
Find out more
Novel Anti-microbial Peptide GL13K
Technology No. 20160093,2019-312, 2019-364
Novel Anti-microbial Peptide GL13K
Find out more
Methods for Modifying Proteins and Peptides.
Technology No. 20180338
Methods for Modifying Proteins and Peptides.
Find out more
Surface markers for identification and isolation of skeletal muscle stem cells
Technology No. 20170019, 20160361
Surface markers for identification and isolation of skeletal muscle stem cells
Find out more
Treating trauma-induced acute blood loss
Technology No. 2017-0028, Z04048
Treating trauma-induced acute blood loss
Find out more
Cell-free selection of site-specific polypeptide binders via tethering
Technology No. 20170034
Cell-free selection of site-specific polypeptide binders via tethering
Find out more
Compound with selective inhibition potential against P300 and CBT
Technology No. 2021-151
Compound with selective inhibition potential against P300 and CBT
Find out more
Live cell assay to quantify the activity of SARS-CoV-2 main protease, Mpro
Technology No. 2021-102
Live cell assay to quantify the activity of SARS-CoV-2 main protease, Mpro
Find out more
Camelid single domain antibody phage display library
Technology No. 2020-220
Camelid single domain antibody phage display library
Find out more
T cell receptors for engineered T cell therapy
Technology No. 2020-202
T cell receptors for engineered T cell therapy
Find out more
A system for unattended delivery of cognitive neuromodulation therapy
Technology No. 2019-125
A system for unattended delivery of cognitive neuromodulation therapy
Find out more
AGRP-derived melanocortin receptor ligands
Technology No. 20160310
AGRP-derived melanocortin receptor ligands
Find out more
Chimeric melanocortin receptor ligands
Technology No. 20160320
Chimeric melanocortin receptor ligands
Find out more
Selective melanocortin receptor ligands
Technology No. 20160305
Selective melanocortin receptor ligands
Find out more
Lateral flow assay for respiratory viruses
Technology No. 2020-309
Lateral flow assay for respiratory viruses
Find out more
Semi-solid polymer drug delivery system
Technology No. 20120102
Semi-solid polymer drug delivery system
Find out more
A novel approach for bioprinting complex tissue models
Technology No. 2020-344
A novel approach for bioprinting complex tissue models
Find out more
Novel anti-cancer agents that target the epigenetic reader protein
Technology No. 2021-055
Novel anti-cancer agents that target the epigenetic reader protein
Find out more
Use of sulfanegen and its analogs for prevention and treatment for neurodegenerative disorders
Technology No. 2020-331
Use of sulfanegen and its analogs for prevention and treatment for neurodegenerative disorders
Find out more
A method to identify cell-free biomarkers of cancers and other diseases
Technology No. 20170056
A method to identify cell-free biomarkers of cancers and other diseases
Find out more
Assessing tumor behavior and response to therapy
Technology No. 20160224
Assessing tumor behavior and response to therapy
Find out more
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
Technology No. 20170362
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
Find out more
Fast and reliable neutralization antibodies assay for AAV gene therapy (2020-121)
Technology No. 2020-121
Fast and reliable neutralization antibodies assay for AAV gene therapy (2020-121)
Find out more
Pharmacological agents to prevent recurrent C. diff infection (20150362)
Technology No. 20150362
Pharmacological agents to prevent recurrent C. diff infection (20150362)
Find out more
A method to genetically engineer monocytes (20180236)
Technology No. 20180236
A method to genetically engineer monocytes (20180236)
Find out more
A streamlined method to isolate Fibroadipogenic progenitor cells from muscle (2020-195)
Technology No. 2020-195
A streamlined method to isolate Fibroadipogenic progenitor cells from muscle (2020-195)
Find out more
PEGylated Fibrin Biomatrix for Treatment of Acute Myocardial Infarction
Technology No. z02201
PEGylated Fibrin Biomatrix for Treatment of Acute Myocardial Infarction
Find out more
Genetic Modification of Endostatin: An Anti-Angiogenic Therapeutic
Technology No. z00094
Genetic Modification of Endostatin: An Anti-Angiogenic Therapeutic
Find out more
More Stable and Potent Cyclic ADP-Ribose Analogs
Technology No. 99184
More Stable and Potent Cyclic ADP-Ribose Analogs
Find out more
Treating Neurodegenerative Diseases with Nicotine Receptor Ligands
Technology No. 99089
Treating Neurodegenerative Diseases with Nicotine Receptor Ligands
Find out more
Modified Sleeping Beauty Transposon Gene Transfer System
Technology No. 99002
Modified Sleeping Beauty Transposon Gene Transfer System
Find out more
Novel process to obtain large quantities of primary cells for transplantation
Technology No. 2020-057
Novel process to obtain large quantities of primary cells for transplantation
Find out more
Dental stem cells to treat spinal cord injury
Technology No. 2019-317
Dental stem cells to treat spinal cord injury
Find out more
CoFe nanowires for remote heating using an alternating magnetic field
Technology No. 2019-122
CoFe nanowires for remote heating using an alternating magnetic field
Find out more
Novel small molecules for chemotherapy sensitization
Technology No. 20180203
Novel small molecules for chemotherapy sensitization
Find out more
MHC Class II Molecules with Enhanced Co-receptor Affinity
Technology No. 20180109
MHC Class II Molecules with Enhanced Co-receptor Affinity
Find out more
Microinjection for Single Cell Gene Manipulation
Technology No. 20180069
Microinjection for Single Cell Gene Manipulation
Find out more
Tosedostat (CHR-2797) as a Potential Analgesic
Technology No. 20180059
Tosedostat (CHR-2797) as a Potential Analgesic
Find out more
Engineering Human CD64 Chimeric Receptors for Immune Therapy
Technology No. 20180040
Engineering Human CD64 Chimeric Receptors for Immune Therapy
Find out more
Real-Time Reporter and Efficient Enzymes for DNA Editing
Technology No. 20170418
Real-Time Reporter and Efficient Enzymes for DNA Editing
Find out more
Rationale Design of Inhibitors based on Crystal Structures of ssDNA Bound to APOBEC
Technology No. 20170124
Rationale Design of Inhibitors based on Crystal Structures of ssDNA Bound to APOBEC
Find out more
Optimizing Gene Editing in NK Cells for Therapy and Research
Technology No. 20160346
Optimizing Gene Editing in NK Cells for Therapy and Research
Find out more
Efficient release of affinity-captured cells
Technology No. 20160236
Efficient release of affinity-captured cells
Find out more
Peptide Activation of T Cells for Cancer Immunotherapy
Technology No. 20160174
Peptide Activation of T Cells for Cancer Immunotherapy
Find out more
Increased efficiency of CRISPR-Cas9 genome editing (Dr. Wendy Gordon)
Technology No. 20160269
Increased efficiency of CRISPR-Cas9 genome editing (Dr. Wendy Gordon)
Find out more
Cryopreservation without Dimethyl Sulfoxide (20140289, Dr. Allison Hubel)
Technology No. 20140289
Cryopreservation without Dimethyl Sulfoxide (20140289, Dr. Allison Hubel)
Find out more
Bacterial Biofilms Targeted with Microbial Drone Therapeutics (20140281, Dr. Christine Salomon)
Technology No. 20140281
Bacterial Biofilms Targeted with Microbial Drone Therapeutics (20140281, Dr. Christine Salomon)
Find out more
Mesoporous Silica-coated Iron Oxide Nanoparticle (20140249, Dr. Christy Haynes)
Technology No. 20140249
Mesoporous Silica-coated Iron Oxide Nanoparticle (20140249, Dr. Christy Haynes)
Find out more
ssDNA Amphiphile Self-Assembly Forms DNA Nanotubes (20140227, Dr. Efie Kokkoli)
Technology No. 20140227
ssDNA Amphiphile Self-Assembly Forms DNA Nanotubes (20140227, Dr. Efie Kokkoli)
Find out more
Small RNA Amplification and Library Preparation (20140020, Dr. Subree Subramanian)
Technology No. 20140020
Small RNA Amplification and Library Preparation (20140020, Dr. Subree Subramanian)
Find out more
Mesoporous silica nanoparticles with ultra high porosity
Technology No. 20140012
Mesoporous silica nanoparticles with ultra high porosity
Find out more
Cerebral Amyloid Angiopathy and Alzheimer’s Disease Diagnosis and Treatment (20130341, Dr. Karunya Kandimalla)
Technology No. 20130341
Cerebral Amyloid Angiopathy and Alzheimer’s Disease Diagnosis and Treatment (20130341, Dr. Karunya Kandimalla)
Find out more
Blood Sugar Regulation with D-serine (20130320, Dr. Amber Lockridge)
Technology No. 20130320
Blood Sugar Regulation with D-serine (20130320, Dr. Amber Lockridge)
Find out more
Reagent for Dual Protein Labeling (20130255, Dr. Mark Distefano)
Technology No. 20130255
Reagent for Dual Protein Labeling (20130255, Dr. Mark Distefano)
Find out more
Immunosuppression Augmented by CD200 Derived Peptide (20130229, Dr. Michael Olin)
Technology No. 20130229
Immunosuppression Augmented by CD200 Derived Peptide (20130229, Dr. Michael Olin)
Find out more
Molecular Probe Measures Nucleosides and Differentiation of ATP and ADP (20120272, Dr. Valerie Pierre)
Technology No. 20120272
Molecular Probe Measures Nucleosides and Differentiation of ATP and ADP (20120272, Dr. Valerie Pierre)
Find out more
Enhancing Cardiac Function Using Short Protein Inhibiting DNAs and RNAs (20120271, Dr. Michael Bowser)
Technology No. 20120271
Enhancing Cardiac Function Using Short Protein Inhibiting DNAs and RNAs (20120271, Dr. Michael Bowser)
Find out more
Controlled Drug Release with Drug Delivery System (20120102, Dr. Chun Wang)
Technology No. 20120102
Controlled Drug Release with Drug Delivery System (20120102, Dr. Chun Wang)
Find out more
Nanoparticle Chemotherapy with Anticancer Prodrugs (20110152, Dr. Thomas Hoye)
Technology No. 20110152
Nanoparticle Chemotherapy with Anticancer Prodrugs (20110152, Dr. Thomas Hoye)
Find out more
Generation of NK and Innate Lymphoid Cells from human stem cells (20110085, Dr. Michael Verneris)
Technology No. 20110085
Generation of NK and Innate Lymphoid Cells from human stem cells (20110085, Dr. Michael Verneris)
Find out more
Cancer Treatment Uses Ornithine Decarboxylase Inhibitor (20110052, Dr. Zigang Dong, Dr. Ann Bode)
Technology No. 20110052
Cancer Treatment Uses Ornithine Decarboxylase Inhibitor (20110052, Dr. Zigang Dong, Dr. Ann Bode)
Find out more
Treating Carcinomas Using Immunotoxin Specific for Cancer Stem Cells (20110014, Dr. John Ohlfest)
Technology No. 20110014
Treating Carcinomas Using Immunotoxin Specific for Cancer Stem Cells (20110014, Dr. John Ohlfest)
Find out more
Cancer Vaccine Adjuvant: Annexin II (20100242)
Technology No. 20100242
Cancer Vaccine Adjuvant: Annexin II (20100242)
Find out more
Lysosomal Storage Disease Enzyme Delivery System (20100076)
Technology No. 20100076
Lysosomal Storage Disease Enzyme Delivery System (20100076)
Find out more
Sarcoma miRNA Expression Database for Cancer Treatment
Technology No. 20090011
Sarcoma miRNA Expression Database for Cancer Treatment
Find out more
Category VIEW ALL
chevron_right
chevron_right
chevron_right
Biologics (39)
Biomarkers (37)
Biomaterials (13)
Biochemicals & Small Molecules (19)
Diagnostics & Imaging (154)
Health IT (40)
Human Health (208)
Industrial Biotech (41)
Medical Devices (163)
MRI & Spectroscopy (66)
Neuroscience (36)
Pharmaceuticals (125)
Medical Questionnaires (10)
Research Tools (142)
Therapeutics (74)
chevron_right
chevron_right
chevron_right